During the past decade, Onkologisches Zentrum Donauwörth conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkologisches Zentrum Donauwörth" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Institute of Clinical Cancer Research (IKF)" with 1 trials as a collaborator and "PharmaMar" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Onkologisches Zentrum Donauwörth" are "Advanced or Metastatic Renal Cell Carcinoma" (1 trials), "Breast Cancer" (1 trials), "HER2-negative Metastatic Breast Cancer" (1 trials), "Hormone Receptor-positive Metastatic Breast Cancer" (1 trials) and "Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Onkologisches Zentrum Donauwörth" in a lesser frequency.

Most popular intervention types in "Onkologisches Zentrum Donauwörth" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib + Aromatase Inhibitor" (1 trials), "Abemaciclib + Fulvestrant" (1 trials), "Atezolizumab" (1 trials), "Trabectidin (Yondelis)" (1 trials) and "trastuzumab [Herceptin]" (1 trials). Other intervention names were less common.

The vast majority of trials in "Onkologisches Zentrum Donauwörth" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Onkologisches Zentrum Donauwörth". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Onkologisches Zentrum Donauwörth, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Onkologisches Zentrum Donauwörth, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".